Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:33:58 EDT Tue 15 Sep 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:NUWE - NUWELLIS INC - https://ir.nuwellis.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NUWE - Q0.10.75·3.950.10.7964+0.02242.9114.2623180.777  0.8065  0.7737180.25  0.711219:47:35Sep 0915 min RT 2¢

Recent Trades - Last 10 of 318
Time ETExPriceChangeVolume
19:47:35Q0.79850.02451
19:30:01Q0.79890.02491
19:05:34Q0.79890.02491,000
18:57:42Q0.79050.0165350
18:56:25Q0.79640.02241
18:56:19Q0.79890.02491
18:05:03Q0.79050.0165204
17:27:00Q0.79640.02248
17:19:04Q0.79640.022432
16:23:16Q0.79640.022410

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-09-09 08:30U:NUWENews ReleaseNuwellis Advances Financial Efficiency Strategy with Improved Gross Margins
2026-08-25 08:30U:NUWENews ReleaseNuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
2026-08-13 08:00U:NUWENews ReleaseNuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin
2026-08-11 03:30U:NUWENews ReleaseNuwellis Accelerates Digital Transformation of the Aquadex(TM) Platform with EHR Connectivity and Enhanced User Interface
2026-08-06 08:30U:NUWENews ReleaseNuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer
2026-08-04 08:30U:NUWENews ReleaseNuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications
2026-07-31 08:39U:NUWENews ReleaseNuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
2026-07-30 08:00U:NUWENews ReleaseNuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy
2026-07-28 08:00U:NUWENews ReleaseNuwellis Expands Pediatric Footprint with First Aquadex SmartFlow(TM) Installations in Wisconsin
2026-07-27 08:30U:NUWENews ReleaseNuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth
2026-07-16 08:30U:NUWENews ReleaseNuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies
2026-07-07 08:00U:NUWENews ReleaseNuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026
2026-06-26 08:00U:NUWENews ReleaseNuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC(sup4))
2026-06-25 08:30U:NUWENews ReleaseNuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow(TM) Installations
2026-06-24 08:30U:NUWENews ReleaseIncoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders
2026-06-18 08:30U:NUWENews ReleaseNuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit
2026-06-16 08:30U:NUWENews ReleaseNuwellis Appoints Mike McCormick as Chief Executive Officer
2026-06-10 08:30U:NUWENews ReleaseNuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow(TM) Devices at One of its Children's Hospitals
2026-06-08 21:47U:NUWENews ReleaseNuwellis Announces Closing of $6.0 Million Registered Public Offering
2026-06-05 08:30U:NUWENews ReleaseNuwellis Announces Pricing of $6 Million Public Offering